CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.
Raninga PV, Zeng B, Moi D, Trethowan E, Saletta F, Venkat P, Mayoh C, D'Souza RCJ, Day BW, Shai-Hee T, Vittorio O, Mazzieri R, Dolcetti R, Khanna KK.
Raninga PV, et al. Among authors: d souza rcj.
Oncogene. 2024 Dec 21. doi: 10.1038/s41388-024-03259-y. Online ahead of print.
Oncogene. 2024.
PMID: 39706891